Rare disease research and treatment development is uniquely challenging given the limited understanding of rare and genetic diseases. De-identified, real-world data (RWD) features claims and electronic health record (EHR) data. Read how this robust, longitudinal patient view makes RWD an invaluable tool for stakeholders across the health system. Download white paper here.
You are here: / / Using Real World Data to Close Rare Disease Gap